National Health Service: How to Cope With Depression The New Anti-Obesity Drugs: What You Should Know Cleveland Clinic: Centers for Disease Control and Prevention: Diabetes and Mental Health Harvard Health Publishing: Weighing in on Weight Gain From Antidepressants Adam Gilden, MD, MSCE Medical Reviewer Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Me
The article's comparison table lists tirzepatide as a dual GLP-1 and GIP agonist with a half-life of roughly five days, against semaglutide as a GLP-1 receptor agonist with a subcutaneous half-life of about seven days
And because rapid weight loss can sometimes mask underlying nutritional or metabolic issues, having access to more detailed health data can be especially valuable
Vomiting Vomiting is less common than nausea but can still occur, especially when the dose is increased
BOOK CONSULT Transform your life with science-backed Our tailored HRT plans use bioidentical hormones to safely and effectively address imbalances, helping you reclaim your energy, mood, and overall wellness
